APLLTD

Alembic Pharmaceuticals LimitedNSE
₹825.1-14.65 (-1.74%)

Market Closed · NSE · INR

Open

₹842.85

High

₹842.85

Low

₹821

Prev Close

₹839.75

52-Week Range46% from low
₹646.55
₹1,036

Market Cap

₹16.51 K Cr

Mid Cap

P/E (TTM)

24.47

EPS

₹34.32

Div Yield

2.74%

P/B Ratio

2.86

ROE

11.8%

Key Metrics

Forward P/E17.32
Book Value₹288.41
Debt/Equity0.24×
Revenue Growth4.4%
Profit Margin10.91%
Operating Margin15.23%
Volume92.8 K
Avg Volume (20d)1.69 L
Delivery %44.42%
Trades8,634

Analyst Ratings(10 analysts)

Buy

Target Price

₹918

+11.3% upside

Strong Buy2
Buy4
Hold3
Sell1
Low: ₹750Median: ₹916High: ₹1,132

Current price: ₹825

Upcoming Events

Ex-Dividend Date
28 Jul 2026

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecol...

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 23.00/share
23
24
25
26
28 Jul 202612.00
29 Jul 202511.00
15 Jul 202411.00
28 Jul 20238.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.